Veeva Systems is a cloud-based software company for the global life sciences industry. Veeva has over 400 customers, including pharmaceutical and biotechnology companies. Founded in 2007, Veeva is a publicly held company headquartered in the San Francisco Bay Area, with offices in Philadelphia, Barcelona, London, Paris, Beijing, Shanghai, and Tokyo.
The company primarily focuses on serving several industries such as cosmetics, consumer goods, chemical, life science, and general business. Their solutions range from quality management to enterprise quality management. Veeva Systems saw an increase in usage during the COVID-19 pandemic, with life sciences and biotechnology companies embracing the software to virtually and remotely conduct business.
The company has various products that offer data, software, and services for the life sciences sector. It has different software and platforms for tasks on topics including clinical, regulatory, quality, safety, medical, and commercial. Its services include consulting, training, and events services.
On February 6, 2007 Veeva Systems announced raising $3 million in angel funding from undisclosed investors.
On June 5, 2008 Veeva Systems announced raising $4 million in ventures funding from Emergence.
The company acquires Crossix and Physicians World.
The company makes its public debut on Wall Street.
The company is funded by Peter Gassner.
June 28, 2017
Veeva debuts single app for managing clinical trial data
September 19, 2018
Veeva Systems is a rare bird: A cloud company that's making money as it goes public
October 16, 2013
Veeva Systems sees product usage increase tenfold as biotech companies race to find COVID-19 cure
March 27, 2020